Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

Latest Post

April 26, 2019

Overcoming Challenges Associated with Biologic Drug Formulation and Development

Standing front and foremost in biologic drug formulation is the optimization of safety and efficacy while ensuring quality and stability during manufacturing. Biologic manufacturing subjects the formulation to different stresses and conditions that may compromise quality and stability. Recently, the requirement for the development of subcutaneous formulations for high dose drugs, such as monoclonal antibodies, at high protein concentrations has created additional challenges, including degradation.
Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Previous Posts
Introducing Integrated Solutions

October 08, 2018

Introducing Integrated Solutions

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

The SmartDose Platform in use

August 10, 2018

Combination Products - Why Design Verification Studies Are Needed

Daniel Bantz

Daniel Bantz

Technical Manager, Packaging & Performance, Lab

SmartDose Platform

August 08, 2018

Performance Testing: Strategies to Qualify Combination Products

Page McAndrew

T. Page McAndrew, Ph.D.

Director, Scientific Communications, SA & TS

Mixject Admixture System

January 30, 2018

Co-Packaged Combination Products – System vs Component

Doug Hostetler

Doug Hostetler

Principle SME, Admin. Systems, TCS